Spero Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2018 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Spero Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2018 to Q3 2022.
  • Spero Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2022 was -92.1 %, a 63.4% decline year-over-year.
  • Spero Therapeutics, Inc. annual Return On Assets for 2021 was -62.1 %, a 2.63% decline from 2020.
  • Spero Therapeutics, Inc. annual Return On Assets for 2020 was -60.5 %, a 15.6% decline from 2019.
  • Spero Therapeutics, Inc. annual Return On Assets for 2019 was -52.3 %, a 31.3% decline from 2018.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -92.1 -35.8 -63.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -86.3 -33.6 -63.9% Apr 1, 2022 Jun 30, 2022
Q1 2022 -71 -17.1 -31.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -62.1 -1.59 -2.63% Oct 1, 2021 Dec 31, 2021
Q3 2021 -56.4 +15.5 +21.6% Jul 1, 2021 Sep 30, 2021
Q2 2021 -52.7 +25.6 +32.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -54 +16.2 +23.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -60.5 -8.17 -15.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -71.9 -33.7 -88.4% Jul 1, 2020 Sep 30, 2020
Q2 2020 -78.3 -47.5 -154% Apr 1, 2020 Jun 30, 2020
Q1 2020 -70.2 -38.9 -124% Jan 1, 2020 Mar 31, 2020
Q4 2019 -52.3 -12.5 -31.3% Oct 1, 2019 Dec 31, 2019
Q3 2019 -38.2 +8.71 +18.6% Jul 1, 2019 Sep 30, 2019
Q2 2019 -30.8 +32.8 +51.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -31.3 Jan 1, 2019 Mar 31, 2019
Q4 2018 -39.8 Oct 1, 2018 Dec 31, 2018
Q3 2018 -46.9 Jul 1, 2018 Sep 30, 2018
Q2 2018 -63.6 Apr 1, 2018 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.